Sontag Advisory »

Iovance Biotherapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $504k 54k 9.39
2024-06-30 $457k 57k 8.02

More positions owned by Sontag Advisory

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Core Total Usd (IUSB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Extend Mkt Etf (VXF)

View all positions for Sontag Advisory

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics